Heart Health Now Linked to Gut Health

A new study, Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets, aims to find the link between gut health and heart health

A new study, "Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets," aims to find the link between gut health and heart health.

Of the probiotics examined, (Cardioviva™) was found to best meet therapeutic lifestyle change (TLC) dietary requirements by:

Blacks Get Treatment on Par With Whites for Cardiovascular Disease
Health outcomes for blacks with cardiovascular disease are similar or better than those of whites when differences in access and treatment are minimized.

Significantly reducing LDL (bad) cholesterol and total cholesterol, with robustness similar to that of existing TLC dietary options,
Improving other coronary heart disease risk factors, such as inflammatory biomarkers, and
Having "generally recognized as safe" (GRAS) status.

Fructose Does Not Impact Emerging Indicator for Cardiovascular Disease
New research has found that fructose, the sugar often blamed for the obesity epidemic, does not itself have any impact on an emerging marker for the risk of cardiovascular disease known as postprandial triglycerides.

Heart disease is a leading cause of death worldwide, and elevated LDL-cholesterol is a major risk factor. Most adults (91 percent) say they care about maintaining a healthy cholesterol level for heart health, but less than half (37 percent) routinely get their cholesterol tested(1).

"People know probiotics for digestive health. They don't associate them with heart health," said Doug DiRienzo, PhD and lead author of the review. "It's time to recognize their potential role as a simple and natural tool in cholesterol management."

Cardiovascular Disease � Beware of This Lethal Killer
Cardiovascular disease (CVD) left an indelible impact on the lives of many in 2004 and nearly one-third of all deaths resulted due the disease.

Randomized double-blinded, placebo-controlled, multicenter trials have shown that Cardioviva™ healthy bacteria lowered total and LDL-cholesterol in hypercholesterolemic adults. In one of these clinical trials involving 127 adults with high cholesterol, those taking a supplement of (Cardioviva™) twice a day had LDL levels 11.6 percent lower than those taking a placebo after nine weeks(2).

"It is exciting to think that certain probiotics, such as Cardioviva™, may have an impact on heart health through gut health," said Penny Kris-Etherton, PhD, RD, Distinguished Professor of Nutrition at the Pennsylvania State University and Fellow of the American Heart Association. "I would encourage consumers who are managing their heart health through diet and exercise to ask their health professionals about probiotics that have been proven effective in lowering cholesterol in clinical trials."

Source-Eurekalert